Total trials
59
Active
5
Phase 3
3
Total enrollment
1,308,633
Pipeline matrix
Showing 4 of 4 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| BCG vaccine | — | — | — | — | — | 3 | |
| Measles vaccine | — | — | — | — | 8 | ||
| Saline placebo | — | — | — | — | — | 1 | |
| BCG vaccination at first health facility contact | — | — | — | — | — | 1 |
Next readouts
- 2025-12-31
- 2026-03
- 2026-12
- 2027-08-01
- 2030-05
Top conditions
- Morbidity13
- Mortality13
- Malaria8
- Measles7
- Infant Mortality5
- Non-specific Effects of Vaccines3
- Heterologous Immunity3
- BCG3
Frequently asked questions about Bandim Health Project
- How many clinical trials does Bandim Health Project have on ClinicalTrials.gov?
- Bandim Health Project is listed as the lead sponsor on 59 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Bandim Health Project's trials are in Phase 3?
- 3 of Bandim Health Project's trials are in Phase 3, spread across 4 active drug programs.
- What therapeutic areas does Bandim Health Project focus on?
- Bandim Health Project's most-studied conditions on ClinicalTrials.gov are Morbidity, Mortality, Malaria, Measles, Infant Mortality.
- When are Bandim Health Project's next clinical trial readouts?
- Bandim Health Project has 5 upcoming primary-completion readouts tracked here; the soonest is “Measles and BCG Vaccines for Mother and Child”, expected around 2025-12-31.